Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

• Status: Completed
• Trial end date: 1969-12-31

Summary

Matching-adjusted indirect comparison of tobramycin solution (TIS) versus aztreonam lysine (AZLI) using TIS patient level clinical trial data and AZLI aggregated clinical trial data from published literature.

Details

• Lead Sponsor: Novartis Pharmaceuticals
• Treatments: Aztreonam; Pharmaceutical Solutions; Tobramycin